CarrieBrownsteinMD

PubMed

• 3 citations
  The 2020 BMT CTN Myeloma Intergroup Workshop on Immune Profiling and Minimal Residual Disease Testing in Multiple Myeloma.
  Sarah A. Holstein, Nizar J. Bahlis, P. Leif Bergsagel, Manisha Bhutani, Niccolo Bolli, Carrie Brownstein, Pierre Demolis, David M. Foureau, Irene M. Ghobrial, Nicole J...> ;Transplantation and Cellular Therapy. 2021 Oct 1
• 40 citations
  A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors.
  Kyriakos P. Papadopoulos, Robin Kate Kelley, Anthony W. Tolcher, Albiruni Ryan Abdul Razak, Katherine Van Loon, Amita Patnaik, Philippe L. Bedard, Ariceli Alfaro, Mura...> ;Clinical Cancer Research. 2016 Mar 15
• 113 citations
  Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Sma...
  Suresh S. Ramalingam, David R. Spigel, David Y. Chen, Martin Steins, Jeffrey A. Engelman, Claus-Peter Schneider, Silvia Novello, Wilfried Eberhardt, Lucio Crinò, Kai H...> ;Journal of Clinical Oncology. 2011 Dec 1
• 74 citations
  Sustainability and Global Seafood
  Martin D. Smith, Cathy A. Roheim, Larry B. Crowder, Benjamin S. Halpern, Mary Turnipseed, James L. Anderson, Frank Asche, Luis Bourillón, Atle G. Guttormsen, Ahmed Kha...> ;Science. 2010 Feb 12
• 9 citations
  Diverse pathways mediate chemotherapy-induced cell death in acute lymphoblastic leukemia cell lines.
  Dong Joon Min, Naomi P. Moskowitz, Carrie Brownstein, Hokyung Lee, Terzah M. Horton, William L. Carroll> ;Apoptosis. 2006 Sep 29
• 28 citations
  A mediator of cell surface-specific plasmin generation.
  Carrie Brownstein, Domenick J. Falcone, Andrew T. Jacovina, Katherine A. Hajjar> ;Annals of the New York Academy of Sciences. 2006 Jan 25
• 43 citations
  Factors that affect final height and change in height standard deviation scores in survivors of childhood cancer treated with growth hormone: a report from the childho...
  Carrie Brownstein, Ann C. Mertens, Pauline Mitby, Marilyn Stovall, Jing Qin, Glenn Heller, Leslie L. Robison, Charles A. Sklar> ;The Journal of Clinical Endocrinology and Metabolism. 2004 Sep 1
• 93 citations
  Annexin II mediates plasminogen-dependent matrix invasion by human monocytes: enhanced expression by macrophages
  Carrie Brownstein, Arunkumar B. Deora, Andrew T. Jacovina, Rebecca Weintraub, Menard M. Gertler, K.M. Faisal Khan, Domenick J. Falcone, Katherine A. Hajjar> ;Blood. 2004 Jan 1
• Join now to see all

Abstracts/Posters

• Health-Related Quality of Life (HRQoL) in Patients with Myelofibrosis Treated with Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2 (JAK2), in the Randomized...
  Carrie Brownstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Fedratinib Induces Spleen Responses in Patients with Myeloproliferative Neoplasm-Associated Intermediate- or High-Risk Myelofibrosis (MF) Previously Exposed to Ruxolit...
  Carrie Brownstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Health-Related Quality of Life (HRQoL) with Fedratinib, a Selective, Oral Inhibitor of Janus Kinase 2 (JAK2), in the Phase II JAKARTA2 Study in Patients with Intermedi...
  Carrie Brownstein, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary Myelofibrosis
  Carrie Brownstein, 61st Annual American Society of Hematology Meeting, 61st Annual American Society of Hematology Meeting - Orlando, FL, 12/9/2019
• Join now to see all